# NRG-BR002 (NCT02364557)

> Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02364557
- Phase: PHASE2, PHASE3
- Status: COMPLETED
- Sponsor: NRG Oncology
- Conditions: Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8; Metastatic Breast Carcinoma; Metastatic Malignant Neoplasm in the Bone; Metastatic Malignant Neoplasm in the Liver; Metastatic Malignant Neoplasm in the Lung; Metastatic Malignant Neoplasm in the Lymph Nodes; Metastatic Malignant Neoplasm in the Spine; Prognostic Stage IV Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8
- Interventions: Stereotactic Body Radiotherapy; Surgery
- Enrollment: 129
- Primary outcome: Progression-free Survival (Phase II)
- Primary outcome: Overall Survival (Phase III)

## Indexed commentary on NRG-BR002 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 91
- YouTube: 11
- Podcasts: 8
- Bluesky threads: 4

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nrg-br002-nct02364557

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02364557", "email": "<work email>"}; the inbox owner confirms by the emailed link.